Abstract
Without overriding financial imperatives, the commercial marketplace for products and services enabling quality improvement, quality assurance, and quality control has been limited in health care. Companies serving this industry have had a difficult time finding business justification to bring these products to market. However, government initiatives in the past 6 years attempting to reduce health care costs are placing an emphasis on better, more appropriate, and more effective health care delivery through evidence-based medicine. Incentives,penalties, and reimbursements for providers serving Medicare and Medicaid patients are being implemented or altered to encourage this adoption. Within this new environment,quality systems become vital tools in managing optimal operations, and thus, a new commercial marketplace is rapidly evolving for vendors to develop, promote, and profitably sell quality assurance and quality control products and services.With a viable, growing, and competitive market, radiologists, technologists, and radiology administrators may look forward to having a wide choice of quality tools to help them make their departments an invaluable resource in a changing healthcare delivery system.
Highlights
The track record of this approach is by no means assured
While it may make for a perceived advantage during the sales process, the additional quality systems may not be utilized due to the penalties discussed
Development of a quality system in the absence of industry-wide standards or requirements often dictates a proprietary system native and limited to that vendor’s products, limiting market potential to a percentage of their installed base and future unit sales. This limited market can be the critical factor in a business assessment
Summary
Products and services affording superior quality assurance or quality control at a premium cost or additional expense have found challenging and limited commercial success. The track record of this approach is by no means assured While it may make for a perceived advantage during the sales process, the additional quality systems may not be utilized due to the penalties (time, personnel) discussed. Development of a quality system in the absence of industry-wide standards or requirements often dictates a proprietary system native and limited to that vendor’s products, limiting market potential to a percentage of their installed base and future unit sales This limited market can be the critical factor in a business assessment. Human work effort and time is needed to translate the insights gained into superior clinical practice This service has not been offered commercially to date
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
